Octreotide Long-Acting Injection and Rifadin IV
Determining the interaction of Octreotide Long-Acting Injection and Rifadin IV and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
Generic Name: rifampin
Brand name: Rifadin IV, Rifadin, Rimactane
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Octreotide Long-Acting Injection-Rifadin IV Intravenous
- Octreotide Long-Acting Injection-Rifamate
- Octreotide Long-Acting Injection-Rifampin
- Octreotide Long-Acting Injection-Rifampin and Isoniazid
- Octreotide Long-Acting Injection-Rifampin Capsules
- Octreotide Long-Acting Injection-Rifampin Injection
- Rifadin IV-Ocu-Carpine
- Rifadin IV-Ocu-Chlor
- Rifadin IV-Ocu-Dex
- Rifadin IV-Ocu-Disal
- Rifadin IV-Ocu-Pentolate
- Rifadin IV-Ocu-Phrin